Brigitte Dupriez
Brigitte Dupriez publishes mostly in Hematology, Genetics and Pathology and Forensic Medicine, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research and Lymphoma Diagnosis and Treatment.
- World rank
- #398,599 of 7,710,434 ranked researchers
- Rank in France
- #21,706 of 324,115
- Works
- 124
- Citations
- 7.1k
- Citations per work
- 57.5
What does Brigitte Dupriez research?
Brigitte Dupriez's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8669.1%
- Medicine8669.1%
- Everything else2923.6%
- Life Sciences97.3%
- 1Hematology26% of their works
- 2Genetics22% of their works
- 3Pathology and Forensic Medicine9% of their works
- 4Rheumatology7% of their works
- 5Molecular Biology7% of their works
- 6Oncology4% of their works
Research topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Eosinophilic Disorders and Syndromes
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- CNS Lymphoma Diagnosis and Treatment
Which keywords describe Brigitte Dupriez's research?
The keywords of their largest research topics: Prognostic Scoring System, JAK2 Mutation, Myelofibrosis, Prognostic Factors, Classification, Acute Myeloid Leukemia, AML and Lymphoma.
- Primary CNS Lymphoma
- International Myeloma Working Group
- Childhood Cancer
- Minimal Residual Disease
- Fusion Genes
- BCR-ABL
- Lymphoma
- AML
- Prognostic Factors
- JAK2 Mutation
- Prognostic Scoring System
- Myelofibrosis
- Classification
- Acute Myeloid Leukemia
- Molecular Profiling
- Imatinib
- Hypereosinophilic Syndrome
- Acute Lymphoblastic Leukemia
- Diagnosis Criteria
- Chemotherapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Scoring System582 topics
- JAK2 Mutation501 topic
- Myelofibrosis501 topic
- Prognostic Factors432 topics
- Classification412 topics
- AML331 topic
- Acute Myeloid Leukemia331 topic
- Lymphoma221 topic
- Molecular Profiling221 topic
- BCR-ABL211 topic
- Imatinib211 topic
- Fusion Genes191 topic
- Hypereosinophilic Syndrome191 topic
- Minimal Residual Disease192 topics
- Acute Lymphoblastic Leukemia101 topic
- Childhood Cancer101 topic
- Diagnosis Criteria91 topic
- International Myeloma Working Group91 topic
- Chemotherapy81 topic
- Primary CNS Lymphoma81 topic
Where does Brigitte Dupriez work?
Brigitte Dupriez's main affiliation in the publication record is Centre Hospitalier de Lens, France.
How many publications and citations does Brigitte Dupriez have?
OpenAlex counts 124 works and 7,136 citations for Brigitte Dupriez, an h-index of 38, ranking #398,599 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Brigitte Dupriez. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.